EU approves €400M German subsidy to keep Sanofi insulin plant open

The European Commission approved a €400 million German state subsidy to prevent Sanofi from closing its Frankfurt insulin production site, citing the need to secure EEA insulin supply. The move signals EU willingness to use state aid to protect critical medicine manufacturing, potentially setting a precedent for industrial health policy.